Yumanity Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch YMTX and buy or sell other stocks, ETFs, and their options commission-free!

About YMTX

Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. 

CEO
Shawn P. Iadonato, PhD
CEOShawn P. Iadonato, PhD
Employees
5
Employees5
Headquarters
Mercer Island, Washington
HeadquartersMercer Island, Washington
Founded
2008
Founded2008
Employees
5
Employees5

YMTX Key Statistics

Market cap
34.53M
Market cap34.53M
Price-Earnings ratio
-0.50
Price-Earnings ratio-0.50
Dividend yield
—
Dividend yield—
Average volume
15.46K
Average volume15.46K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.15
52 Week high$1.15
52 Week low
$0.1806
52 Week low$0.1806

People also own

Based on the portfolios of people who own YMTX. This list is generated using Robinhood data, and it’s not a recommendation.
Virgin Galactic Holdings
Ocugen, Inc
Shift Technologies
Exela Technologies
Tonix Pharmaceuticals
Ford Motor
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.